MPR Weekly Dose

MPR Weekly Dose

Each week the MPR team brings you the top stories from the world of medicine and pharma in a matter of minutes. With 35 years of publishing drug information behind us, you can rely on MPR to provide accurate and up-to-date news.

Tämä podcast on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi podcastin jaksot saattavat sisältää mainontaa.

Jaksot(275)

MPR Weekly Dose #60 - The FDA stand by remdesivir; Who should get the vaccine first? Xolair and Hetlioz gain expanded approvals; And a novel neuroblastoma treatment

MPR Weekly Dose #60 - The FDA stand by remdesivir; Who should get the vaccine first? Xolair and Hetlioz gain expanded approvals; And a novel neuroblastoma treatment

This week we cover a back and forth between the FDA and the WHO over remdesivir efficacy; Recommendations for who should get a COVID vaccine first; Xolair and Hetlioz have approval expansions; And a n...

4 Joulu 20209min

MPR Weekly Dose #59 - The latest on vaccine news from Moderna, and BioNTech and Pfizer as they release more trial data; A at-home diagnostic test; Keytruda gains expanded approval; and more

MPR Weekly Dose #59 - The latest on vaccine news from Moderna, and BioNTech and Pfizer as they release more trial data; A at-home diagnostic test; Keytruda gains expanded approval; and more

The latest on vaccine news from Moderna, and BioNTech and Pfizer as they release more trial data; A at-home diagnostic test is approved; Keytruda gains expanded approval; and all the rest of the drug ...

20 Marras 202011min

MPR Weekly Dose #58 - Major developments in COVID vaccine and antibody treatments; Also an FDA Advisory Committee vote on what would be the first Alzheimer drug in decades.

MPR Weekly Dose #58 - Major developments in COVID vaccine and antibody treatments; Also an FDA Advisory Committee vote on what would be the first Alzheimer drug in decades.

Major developments in COVID-19 vaccine and antibody treatments: Are we close to having a vaccine gain Emergency Use Authorization? The antibody bamlanivimab is given Emergency Use Authorization; An NI...

13 Marras 202012min

MPR Weekly Dose #57 - NDA in diabetes; Post-op implant pain Tx; DEA schedules new opioid; FDA lists 200+ drugs; Rifaximin and other drugs in the pipeline news

MPR Weekly Dose #57 - NDA in diabetes; Post-op implant pain Tx; DEA schedules new opioid; FDA lists 200+ drugs; Rifaximin and other drugs in the pipeline news

This week we cover a new treatment submission to the FDA for the prevention of diabetes; The launch of a bupivacaine implant to treat post op pain; The DEA schedules a newly approved opioid; The FDA c...

6 Marras 20209min

MPR Weekly Dose Episode #56 - Antibody responses; Convalescent plasma; Nasal spray for diabetic gastroparesis; Colorectal cancer screening recommendations; New dry eye treatment; And movie trivia!

MPR Weekly Dose Episode #56 - Antibody responses; Convalescent plasma; Nasal spray for diabetic gastroparesis; Colorectal cancer screening recommendations; New dry eye treatment; And movie trivia!

This week: The study that identified factors associated with strong antibody responses to COVID; How convalescent plasmas benefits may be limited; A nasal spray to treat diabetic gastroparesis; Recomm...

30 Loka 20206min

MPR Weekly Dose Podcast Episode 55

MPR Weekly Dose Podcast Episode 55

This week on the pod: Results from the survey assessing willingness to receive a COVID vaccine; Dr. Fauci shares that he is 'cautiously optimistic' a vaccine could arrive before year's end; A short co...

23 Loka 202011min

Weekly Dose #54 - Vaccine trial halted; Hyperimmune trial begins; IV tramadol rejected; FDA votes on schizophrenia, bipolar Tx; And a first in Ebola treatment

Weekly Dose #54 - Vaccine trial halted; Hyperimmune trial begins; IV tramadol rejected; FDA votes on schizophrenia, bipolar Tx; And a first in Ebola treatment

This week: News of another vaccine trial being put on hold; A trial assessing hyperimmue globulin beings; An NDA for IV tramadol is rejected; FDA Committees vote on novel schizophrenia and bipolar I d...

16 Loka 20209min

Weekly Dose #53 - Encouraging news on antibody therapies; EUA guidelines for potential vaccines; Remdesivir distribution; The HIV drug that failed to have an impact; And the preterm birth treatment the FDA want withdrawn from the market.

Weekly Dose #53 - Encouraging news on antibody therapies; EUA guidelines for potential vaccines; Remdesivir distribution; The HIV drug that failed to have an impact; And the preterm birth treatment the FDA want withdrawn from the market.

This week on the pod; the latest COVID news, including encouraging news on antibody therapies; Updated on Emergency Use Authorization guidelines for vaccines; Remdesivir distribution; A HIV drug fails...

9 Loka 202010min

Suosittua kategoriassa Terveys ja hyvinvointi

unicast
psykopodiaa-podcast
rss-pitaisko-erota
tiedenaiset-podcast
vakeva-elama-viisaampi-mieli-vahvempi-keho
voi-hyvin-meditaatiot-2
puhu-muru
rss-kuumilla-aalloilla
rss-narsisti
katilon-kahvitunti
meditaatiot-suomeksi
terapiassa
rss-uplevel-by-sonja-hannus
rss-pt-paahtio
rss-nautinto
junnut-pelissa
monisuhteellista
traumapodi
rss-terapiaklubi
fitnessvastaanotto